• 1
    Choi YL, Cho EY, Kim JH, et al. Detection of human papillomavirus DNA by DNA chip in breast carcinomas of Korean women. Tumour Biol. 2007; 28: 327-332.
  • 2
    Damin AP, Karam R, Zettler CG, Caleffi M, Alexandre CO. Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res Treat. 2004; 84: 131-137.
  • 3
    de Leon DC, Montiel DP, Nemcova J, et al. Human papillomavirus (HPV) in breast tumors: prevalence in a group of Mexican patients [serial online]. BMC Cancer. 2009; 9: 26.
  • 4
    de Villiers EM, Sandstrom RE, zur Hausen H, Buck CE. Presence of papillomavirus sequences in condylomatous lesions of the mammillae and in invasive carcinoma of the breast. Breast Cancer Res. 2005; 7: R1-R11.
  • 5
    Di Lonardo A, Venuti A, Marcante ML. Human papillomavirus in breast cancer. Breast Cancer Res Treat. 1992; 21: 95-100.
  • 6
    Gumus M, Yumuk PF, Salepci T, et al. HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples. J Exp Clin Cancer Res. 2006; 25: 515-521.
  • 7
    Heng B, Glenn WK, Ye Y, et al. Human papilloma virus is associated with breast cancer. Br J Cancer. 2009; 101: 1345-1350.
  • 8
    Hennig EM, Di Lonardo A, Venuti A, Holm R, Marcante ML, Nesland JM. HPV 16 in multiple neoplastic lesions in women with CIN III. J Exp Clin Cancer Res. 1999; 18: 369-377.
  • 9
    Kan CY, Iacopetta BJ, Lawson JS, Whitaker NJ. Identification of human papillomavirus DNA gene sequences in human breast cancer. Br J Cancer. 2005; 93: 946-948.
  • 10
    Khan NA, Castillo A, Koriyama C, et al. Human papillomavirus detected in female breast carcinomas in Japan. Br J Cancer. 2008; 99: 408-414.
  • 11
    Kroupis C, Markou A, Vourlidis N, Dionyssiou-Asteriou A, Lianidou ES. Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clin Biochem. 2006; 39: 727-731.
  • 12
    Li T, Lu ZM, Guo M, et al. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Cancer. 2002; 95: 2571-2576.
  • 13
    Liu Y, Klimberg VS, Andrews NR, et al. Human papillomavirus DNA is present in a subset of unselected breast cancers. J Hum Virol. 2001; 4: 329-334.
  • 14
    Tsai JH, Tsai CH, Cheng MH, Lin SJ, Xu FL, Yang CC. Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol. 2005; 75: 276-281.
  • 15
    Widschwendter A, Brunhuber T, Wiedemair A, Mueller-Holzner E, Marth C. Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J Clin Virol. 2004; 31: 292-297.
  • 16
    Yu Y, Morimoto T, Sasa M, et al. HPV33 DNA in premalignant and malignant breast lesions in Chinese and Japanese populations. Anticancer Res. 1999; 19( 6B): 5057-5061.
  • 17
    Yu Y, Morimoto T, Sasa M, et al. Human papillomavirus type 33 DNA in breast cancer in Chinese. Breast Cancer. 2000; 7: 33-36.
  • 18
    Nuovo GJ. The utility of in situ-based methodologies including in situ polymerase chain reaction for the diagnosis and study of viral infections. Hum Pathol. 2007; 38: 1123-1136.
  • 19
    Patillo RA, Hussa RO, Story MT, Ruckert AC, Shalaby MR, Mattingly RF. Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. Science. 1997; 196: 1456-1458.
  • 20
    Nuovo GJ. PCR in Situ Hybridization: Protocols and Applications. Philadelphia, PA: Lippincott-Raven; 1996.
  • 21
    Fontaine V, Mascaux C, Weyn C, et al. Evaluation of combined general primer-mediated PCR sequencing and type-specific PCR strategies for determination of human papillomavirus genotypes in cervical cell specimens. J Clin Microbiol. 2007; 45: 928-934.
  • 22
    Fitzgibbons PL, Henson DE, Hutter RV. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med. 1998; 122: 1053-1055.
  • 23
    Li N, Bi X, Zhang Y, Zhao P, Zheng T, Dai M. Human papillomavirus infection and sporadic breast carcinoma risk: a meta-analysis. Breast Cancer Res Treat. 2011; 126: 515-520.
  • 24
    Bratthauer GL, Tavassoli FA, O'Leary TJ. Etiology of breast carcinoma: no apparent role for papillomavirus types 6/11/16/18. Pathol Res Pract. 1992; 188: 384-386.
  • 25
    Schiffman M, Castle PE. The promise of global cervical-cancer prevention. N Engl J Med. 2005; 353: 2101-2104.
  • 26
    Gopalkrishna V, Singh UR, Sodhani P, et al. Absence of human papillomavirus DNA in breast cancer as revealed by polymerase chain reaction. Breast Cancer Res Treat. 1996; 39: 197-202.
  • 27
    Howley PM, Lowy DR. Papillomaviruses and their replication. In: Knipe DM, Howley PM, eds. Fields Virology. Fifth ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007.
  • 28
    Chu TY, Shen SY, Lee HS, Liu HS. Monoclonality and surface lesion-specific microsatellite alterations in premalignant and malignant neoplasia of uterine cervix: a local field effect of genomic instability and clonal evolution. Genes Chromosomes Cancer. 1999; 24: 127-134.
  • 29
    Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer. 1953; 6: 963-968.
  • 30
    Heaphy CM, Griffith JK, Bisoffi M. Molecular field cancerization: molecular evidence and clinical importance. Breast Cancer Res Treat. 2009; 118: 229-239.